Cara Therapeutics Announces Pricing of Initial Public Offering SHELTON, Conn., Jan. 31, 2014 -- Cara Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors, today announced the pricing of its initial public offering of ... (more)
via Shelton Newswire http://ift.tt/MEJ6Fg
via Shelton Newswire http://ift.tt/MEJ6Fg
No comments:
Post a Comment